ERIC NGHE: Open Payments
NPI 1417466368 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 45 payments from 7 companies in 2025. Trend: 2023 $893 · 2024 $1,440 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $369 |
| Axsome Therapeutics, Inc. | 14 | $302 |
| Otsuka America Pharmaceutical, Inc. | 5 | $292 |
| ABBVIE INC. | 8 | $246 |
| Vanda Pharmaceuticals Inc. | 7 | $205 |
| Lundbeck LLC | 6 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
Products named: REXULTI, Auvelity, VRAYLAR, UZEDY, FANAPT, AUSTEDO XR, CAPLYTA.
Industry payments across CA — which companies pay providers there.
